Invokana and Thirst - a phase IV clinical study of FDA data

Summary:

Thirst is reported as a side effect among people who take Invokana (canagliflozin), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Metformin, and have High blood cholesterol.

The phase IV clinical study analyzes which people have Thirst when taking Invokana. It is created by eHealthMe based on reports of 29,682 people who have side effects when taking Invokana from the FDA, and is updated regularly.

What is Invokana?

Invokana has active ingredients of canagliflozin. It is often used in diabetes. eHealthMe is studying from 29,937 Invokana users. Check the latest studies of Invokana.

What is Thirst?

Thirst is found to be associated with 1,183 drugs and 1,324 conditions by eHealthMe. Check the latest studies of Thirst.

On Jul, 07, 2026

29,682 people reported to have side effects when taking Invokana.
Among them, 200 people (0.67%) have Thirst.

Among these 200 people:

* Approximation only. Some reports may have incomplete information.

Do you take Invokana and have Thirst?

- Check whether Thirst is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Invokana:

Invokana (29,937 reports)

Thirst treatments and more:

Thirst (21,000 reports)

How severe was Thirst and when was it recovered:

Thirst in Invokana

Expand to all the drugs that have ingredients of canagliflozin:

Thirst and drugs with ingredients of canagliflozin (215 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Invokana:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Thirst:

Thirst (1,183 drugs)

Browse all the conditions that are associated with Thirst:

Thirst (1,324 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on canagliflozin (the active ingredients of Invokana) and Invokana (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.